The effect of sulfhydryl inhibitors on substrate oxidation and proline transport with membrane preparations from Mycobacterium phlei.
D000693:Anaerobiosis; D001128:Argon / Q000494:pharmacology; D001205:Ascorbic Acid / Q000378:metabolism; D001692:Biological Transport; D002250:Carbon Radioisotopes; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism; D002729:Chloromercuribenzoates / Q000494:pharmacology; D005033:Ethylmaleimide / Q000494:pharmacology; D007700:Kinetics; D009161:Mycobacterium / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D009243:NAD / Q000378:metabolism; D009942:Organometallic Compounds / Q000494:pharmacology; D010101:Oxygen Consumption; D010619:Phenazines / Q000378:metabolism; D011392:Proline / Q000378:metabolism*; D013053:Spectrophotometry; D013386:Succinates / Q000378:metabolism; D013439:Sulfhydryl Reagents / Q000494:pharmacology*; D013451:Sulfonic Acids / Q000494:pharmacology; D013997:Time Factors
D002250:Carbon Radioisotopes; D002729:Chloromercuribenzoates; D009942:Organometallic Compounds; D010619:Phenazines; D013386:Succinates; D013439:Sulfhydryl Reagents; D013451:Sulfonic Acids; D009243:NAD; D001128:Argon; D011392:Proline; D005033:Ethylmaleimide; D001205:Ascorbic Acid